Miseon Lee

Miseon Lee is a Senior Scientist at Boehringer Ingelheim since January 2020, with prior experience as a Postdoctoral Associate at the Broad Institute of MIT and Harvard from June 2017 to January 2020, where research focused on CRISPR-Cas9 small-molecule inhibitors and targeted methodologies for β-cell delivery. As a Graduate Research Assistant at Temple University from August 2010 to May 2017, responsibilities included the synthesis of antibiotic compounds and development of lead compounds for in situ click chemistry, alongside teaching General Chemistry and Organic Chemistry. Miseon Lee's academic background includes a PhD in Organic Chemistry from Temple University, a Master's degree in Pharmacy from Seoul National University, and a Bachelor's degree in Chemistry from Sogang University.